Daysee Tablets

Lupin Pharmaceuticals Obtained Final Marketing Approval From FDA for Its Daysee Tablets
Apr 16, 2013
Lupin Pharmaceuticals has obtained final marketing approval from FDA for its Daysee tablets (Levonorgestrel and Ethinyl Estradiol Tablets, USP, 0.15mg/0.03mg and Ethinyl Estradiol Tablets, USP, 0.01mg). The company commenced the shipment ...

Tags: Lupin, FDA Marketing Approval, Daysee Tablets